2024-04-012025-03-312025-03-31false08251553LONDON SURGICAL CENTRE LIMITED2025-12-0286900falseiso4217:GBPxbrli:pure082515532024-03-31082515532025-03-31082515532024-04-012025-03-31082515532023-03-31082515532024-03-31082515532023-04-012024-03-3108251553bus:SmallEntities2024-04-012025-03-3108251553bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3108251553bus:FullAccounts2024-04-012025-03-3108251553bus:PrivateLimitedCompanyLtd2024-04-012025-03-3108251553core:WithinOneYear2025-03-3108251553core:AfterOneYear2025-03-3108251553core:WithinOneYear2024-03-3108251553core:AfterOneYear2024-03-3108251553core:ShareCapital2025-03-3108251553core:SharePremium2025-03-3108251553core:RevaluationReserve2025-03-3108251553core:OtherReservesSubtotal2025-03-3108251553core:RetainedEarningsAccumulatedLosses2025-03-3108251553core:ShareCapital2024-03-3108251553core:SharePremium2024-03-3108251553core:RevaluationReserve2024-03-3108251553core:OtherReservesSubtotal2024-03-3108251553core:RetainedEarningsAccumulatedLosses2024-03-3108251553core:LandBuildings2025-03-3108251553core:PlantMachinery2025-03-3108251553core:Vehicles2025-03-3108251553core:FurnitureFittings2025-03-3108251553core:OfficeEquipment2025-03-3108251553core:NetGoodwill2025-03-3108251553core:IntangibleAssetsOtherThanGoodwill2025-03-3108251553core:ListedExchangeTraded2025-03-3108251553core:UnlistedNon-exchangeTraded2025-03-3108251553core:LandBuildings2024-03-3108251553core:PlantMachinery2024-03-3108251553core:Vehicles2024-03-3108251553core:FurnitureFittings2024-03-3108251553core:OfficeEquipment2024-03-3108251553core:NetGoodwill2024-03-3108251553core:IntangibleAssetsOtherThanGoodwill2024-03-3108251553core:ListedExchangeTraded2024-03-3108251553core:UnlistedNon-exchangeTraded2024-03-3108251553core:LandBuildings2024-04-012025-03-3108251553core:PlantMachinery2024-04-012025-03-3108251553core:Vehicles2024-04-012025-03-3108251553core:FurnitureFittings2024-04-012025-03-3108251553core:OfficeEquipment2024-04-012025-03-3108251553core:NetGoodwill2024-04-012025-03-3108251553core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108251553core:ListedExchangeTraded2024-04-012025-03-3108251553core:UnlistedNon-exchangeTraded2024-04-012025-03-3108251553core:MoreThanFiveYears2024-04-012025-03-3108251553core:Non-currentFinancialInstruments2025-03-3108251553core:Non-currentFinancialInstruments2024-03-3108251553dpl:CostSales2024-04-012025-03-3108251553dpl:DistributionCosts2024-04-012025-03-3108251553core:LandBuildings2024-04-012025-03-3108251553core:PlantMachinery2024-04-012025-03-3108251553core:Vehicles2024-04-012025-03-3108251553core:FurnitureFittings2024-04-012025-03-3108251553core:OfficeEquipment2024-04-012025-03-3108251553dpl:AdministrativeExpenses2024-04-012025-03-3108251553core:NetGoodwill2024-04-012025-03-3108251553core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108251553dpl:GroupUndertakings2024-04-012025-03-3108251553dpl:ParticipatingInterests2024-04-012025-03-3108251553dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108251553core:ListedExchangeTraded2024-04-012025-03-3108251553dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108251553core:UnlistedNon-exchangeTraded2024-04-012025-03-3108251553dpl:CostSales2023-04-012024-03-3108251553dpl:DistributionCosts2023-04-012024-03-3108251553core:LandBuildings2023-04-012024-03-3108251553core:PlantMachinery2023-04-012024-03-3108251553core:Vehicles2023-04-012024-03-3108251553core:FurnitureFittings2023-04-012024-03-3108251553core:OfficeEquipment2023-04-012024-03-3108251553dpl:AdministrativeExpenses2023-04-012024-03-3108251553core:NetGoodwill2023-04-012024-03-3108251553core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108251553dpl:GroupUndertakings2023-04-012024-03-3108251553dpl:ParticipatingInterests2023-04-012024-03-3108251553dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108251553core:ListedExchangeTraded2023-04-012024-03-3108251553dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108251553core:UnlistedNon-exchangeTraded2023-04-012024-03-3108251553core:NetGoodwill2025-03-3108251553core:IntangibleAssetsOtherThanGoodwill2025-03-3108251553core:LandBuildings2025-03-3108251553core:PlantMachinery2025-03-3108251553core:Vehicles2025-03-3108251553core:FurnitureFittings2025-03-3108251553core:OfficeEquipment2025-03-3108251553core:AfterOneYear2025-03-3108251553core:WithinOneYear2025-03-3108251553core:ListedExchangeTraded2025-03-3108251553core:UnlistedNon-exchangeTraded2025-03-3108251553core:ShareCapital2025-03-3108251553core:SharePremium2025-03-3108251553core:RevaluationReserve2025-03-3108251553core:OtherReservesSubtotal2025-03-3108251553core:RetainedEarningsAccumulatedLosses2025-03-3108251553core:NetGoodwill2024-03-3108251553core:IntangibleAssetsOtherThanGoodwill2024-03-3108251553core:LandBuildings2024-03-3108251553core:PlantMachinery2024-03-3108251553core:Vehicles2024-03-3108251553core:FurnitureFittings2024-03-3108251553core:OfficeEquipment2024-03-3108251553core:AfterOneYear2024-03-3108251553core:WithinOneYear2024-03-3108251553core:ListedExchangeTraded2024-03-3108251553core:UnlistedNon-exchangeTraded2024-03-3108251553core:ShareCapital2024-03-3108251553core:SharePremium2024-03-3108251553core:RevaluationReserve2024-03-3108251553core:OtherReservesSubtotal2024-03-3108251553core:RetainedEarningsAccumulatedLosses2024-03-3108251553core:NetGoodwill2023-03-3108251553core:IntangibleAssetsOtherThanGoodwill2023-03-3108251553core:LandBuildings2023-03-3108251553core:PlantMachinery2023-03-3108251553core:Vehicles2023-03-3108251553core:FurnitureFittings2023-03-3108251553core:OfficeEquipment2023-03-3108251553core:AfterOneYear2023-03-3108251553core:WithinOneYear2023-03-3108251553core:ListedExchangeTraded2023-03-3108251553core:UnlistedNon-exchangeTraded2023-03-3108251553core:ShareCapital2023-03-3108251553core:SharePremium2023-03-3108251553core:RevaluationReserve2023-03-3108251553core:OtherReservesSubtotal2023-03-3108251553core:RetainedEarningsAccumulatedLosses2023-03-3108251553core:AfterOneYear2024-04-012025-03-3108251553core:WithinOneYear2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108251553core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108251553core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108251553core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108251553core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108251553core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108251553core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108251553core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108251553core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108251553core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108251553core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108251553core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108251553core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108251553core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108251553core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108251553core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108251553core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108251553core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108251553core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108251553bus:Director12024-04-012025-03-3108251553bus:Director22024-04-012025-03-3108251553core:FurnitureFittingsToolsEquipment2024-03-3108251553core:FurnitureFittingsToolsEquipment2024-04-012025-03-3108251553core:FurnitureFittingsToolsEquipment2025-03-31

LONDON SURGICAL CENTRE LIMITED

Registered Number
08251553
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

LONDON SURGICAL CENTRE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

HOWLADER, Farhana Afroz
HOWLADER, Mohammad Hossain

Company Secretary

HOWLADER, Mohammad Hossain

Registered Address

93 Windsor Road
London
E7 0RA

Registered Number

08251553 (England and Wales)
LONDON SURGICAL CENTRE LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets398,30772,073
Investment property4445,858445,858
544,165517,931
Current assets
Debtors5,61,487,0881,248,913
Cash at bank and on hand4,571127,683
1,491,6591,376,596
Creditors amounts falling due within one year7(101,007)(198,277)
Net current assets (liabilities)1,390,6521,178,319
Total assets less current liabilities1,934,8171,696,250
Net assets1,934,8171,696,250
Capital and reserves
Called up share capital240240
Profit and loss account1,934,5771,696,010
Shareholders' funds1,934,8171,696,250
The financial statements were approved and authorised for issue by the Board of Directors on 2 December 2025, and are signed on its behalf by:
HOWLADER, Mohammad Hossain
Director
Registered Company No. 08251553
LONDON SURGICAL CENTRE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Land and buildings20
Fixtures and fittings4
Vehicles5
Office Equipment4
Investment property
The investment property is accounted for under FRS 102, Section 16 Investment Property. Investment property is remeasured to fair value at each balance sheet date with fair value gains and losses being reported in profit or loss. Investment properties are valued using RICS open market valuation on a freehold basis.
2.Average number of employees

20252024
Average number of employees during the year54
3.Tangible fixed assets

Land & buildings

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 2475,192-2964,39479,882
Additions-38,205--38,205
At 31 March 2575,19238,2052964,394118,087
Depreciation and impairment
At 01 April 244,260-2963,2537,809
Charge for year3,7607,641-57011,971
At 31 March 258,0207,6412963,82319,780
Net book value
At 31 March 2567,17230,564-57198,307
At 31 March 2470,932--1,14172,073
4.Investment property

£
Fair value at 01 April 24445,858
At 31 March 25445,858
5.Debtors: amounts due within one year

2025

2024

££
Prepayments and accrued income-1,800
Total-1,800
6.Debtors: amounts due after one year

2025

2024

££
Other debtors1,487,0881,247,113
Total1,487,0881,247,113
7.Creditors: amounts due within one year

2025

2024

££
Taxation and social security90,774188,517
Accrued liabilities and deferred income10,2339,760
Total101,007198,277